Elanco Animal Health Appoints Eli Lilly Veteran Jamie Preston as Executive Vice President and Chief People Officer

Main Facts

Elanco Animal Health Incorporated (NYSE: ELAN) has officially announced a pivotal leadership transition within its executive ranks, naming pharmaceutical veteran Jamie Preston as its new Executive Vice President and Chief People Officer, effective November 3. Preston steps into the role following a rigorous, highly competitive global executive search conducted by the company. Her appointment underscores Elanco’s ongoing strategic commitment to attracting, developing, and retaining a deeply engaged international workforce while seamlessly embedding core principles of inclusion, employee well-being, and corporate purpose into its day-to-day global operations.

Preston succeeds outgoing Chief People Officer Dave Kinard, who has announced his retirement set for the conclusion of the calendar year. To guarantee a frictionless leadership handoff and maintain continuity across Elanco’s global human resources operations, Kinard will collaborate closely with Preston throughout the coming months, assisting in the transition of strategic workforce initiatives.

Preston transitions to Elanco after an impressive 23-year career at Eli Lilly and Company, where she spent nearly two decades ascending through various high-level human resources leadership positions. In her most recent capacity as Vice President of HR for Global Compensation and Workforce Innovation, Preston directed the compensation, benefits, and total rewards strategies for Lilly’s sprawling, 50,000-plus employee global enterprise. Furthermore, she spearheaded cutting-edge, enterprise-wide artificial intelligence (AI) and workforce modernization initiatives, positioning her as a forward-thinking leader in human capital digital transformation.

As Executive Vice President and Chief People Officer at Elanco, Preston will assume responsibility for steering the company’s worldwide human resources organization. Her portfolio will encompass global talent acquisition, organizational design, leadership development, compensation and benefits, inclusion and diversity initiatives, and the ongoing digital evolution of the company’s workplace strategies. She will report directly to Elanco President and Chief Executive Officer Jeff Simmons and will serve as a core member of the executive committee driving the company’s long-term business strategy.

Chronology

To fully understand Jamie Preston’s trajectory to the executive suite at Elanco, it is essential to examine the chronological progression of her extensive career in the life sciences and healthcare sectors, alongside the parallel timeline of Elanco’s corporate evolution.

Early Career and Entry into Eli Lilly (Late 1990s – 2000s)

Preston’s professional journey within the pharmaceutical and life sciences ecosystem began at Eli Lilly and Company. Initially entering the corporate fold through the company’s sales organization, Preston gained foundational, ground-level insight into commercial operations, market dynamics, and customer engagement. This early exposure to the commercial side of the healthcare business provided her with a pragmatic, business-oriented perspective that would later distinguish her approach to human resources management.

International HR Leadership and Regional Expansion (2010s)

Transitioning into human resources leadership, Preston quickly demonstrated a capacity for managing complex organizational structures across diverse geographical and cultural landscapes. Her career milestones during this decade included:

• HR Director for Lilly Japan: In this capacity, Preston provided comprehensive HR partnership to the company’s intricate research and development (R&D) organization in Japan, navigating specialized talent retention and scientific recruitment within a highly competitive market.
• Global People Strategy for Oncology: She stepped into a broader strategic role leading global people strategy for Lilly’s multi-billion-dollar Oncology Business Unit, aligning human capital initiatives with aggressive drug development timelines and commercialization goals.
• Associate Vice President of HR across Asia-Pacific: Preston’s remit expanded significantly when she was tapped to oversee human resources operations across five distinct countries: Australia, New Zealand, Taiwan, Korea, and Hong Kong. During her tenure in this multi-market role, she played a vital operational part in supporting the region’s growth into a billion-dollar business hub for the corporation, managing cross-cultural integration, localized labor compliance, and regional talent scaling.

Domestic HR Strategy and Workforce Modernization (Recent Years)

Returning to domestic and global headquarters responsibilities, Preston took on increasingly senior portfolios at Lilly:

• Vice President of HR, Global Compensation and Workforce Innovation: In this capstone role prior to joining Elanco, Preston oversaw total rewards for a workforce exceeding 50,000 employees worldwide. Simultaneously, she took the helm of enterprise-wide initiatives centered on artificial intelligence integration and workforce modernization, preparing the multinational organization for the future of work.

The Elanco Transition Timeline (Late 2024)

• Competitive Executive Search: Elanco undertakes a comprehensive, multi-month global search to identify a visionary HR leader capable of building upon the foundation established during the company’s transition to an independent entity.
• Announcement (Fall 2024): Elanco publicly announces Jamie Preston’s appointment as Executive Vice President and Chief People Officer.
• Effective Date (November 3): Preston officially assumes her duties at Elanco.
• Transition Period (November – December 2024): Retiring CPO Dave Kinard partners with Preston to ensure continuity across global HR operations.
• Retirement of Dave Kinard (December 31, 2024): Kinard concludes his distinguished tenure following the successful relocation of Elanco’s headquarters and the stabilization of post-IPO employee engagement metrics.

Supporting Data

A comprehensive analysis of Jamie Preston’s qualifications, academic background, board memberships, and the institutional metrics of Elanco Animal Health highlights the depth of expertise backing this executive appointment.

Educational Background and Professional Certifications

• Wharton School, University of Pennsylvania: Preston is a graduate of the prestigious Chief Human Resources Officer (CHRO) Program, an executive education curriculum designed to prepare top-tier HR leaders for enterprise-wide governance, strategic financial stewardship, and board-level collaboration.
• University of Evansville: Preston earned both her Master of Health Service Administration and her Bachelor of Health Service Administration degrees from the University of Evansville, grounding her corporate career in a rigorous understanding of healthcare administration and institutional management.

Philanthropic and Community Leadership

Beyond her corporate obligations, Preston maintains an active profile in civic and nonprofit governance:

• Teach for America, Indianapolis: She serves as an active member of the Board of Directors, contributing her strategic acumen to educational equity and leadership development initiatives within the local community.
• Cancer Support Community Central Indiana: Previously, Preston lent her time, expertise, and governance oversight to the board of this regional nonprofit, supporting patients and families navigating cancer diagnoses.

Elanco Animal Health: Corporate Footprint and Workforce Metrics

• Global Presence: Elanco operates in nearly 90 countries, delivering products and services to veterinarians, pet owners, and livestock producers across the globe.
• Workforce Engagement: Under outgoing CPO Dave Kinard, Elanco achieved its highest employee engagement scores since its Initial Public Offering (IPO), reflecting robust cultural integration following its separation from Eli Lilly.
• The One Health Innovation District: A signature infrastructure achievement overseen during Kinard’s tenure includes the relocation of Elanco’s global headquarters from Greenfield to Indianapolis, anchoring the newly established "One Health Innovation District"—a purpose-built life sciences hub developed in partnership with Purdue University.

Official Responses

Leadership at Elanco Animal Health expressed immense enthusiasm regarding the appointment of Jamie Preston and paid tribute to the foundational contributions of retiring executive Dave Kinard.

Jeff Simmons, President and Chief Executive Officer of Elanco, emphasized Preston’s unique blend of corporate agility and deep-rooted industry understanding:

"Jamie is a visionary, dynamic leader with the speed and agility that defines Elanco. She has deep global experience across every facet of human resources, from organizational design and talent development to workforce innovation and digital transformation," Simmons stated.

He added: "As Elanco continues to drive growth and deliver on our purpose of enriching the lives of animals and people, Jamie’s proven track record of building high-performing, inclusive cultures and shaping forward-looking workforce strategies makes her an ideal fit for our executive team. Her shared heritage with our roots at Lilly brings a deep understanding of values-based, science-driven organizations."

In her own statement addressing her new role, Jamie Preston expressed a profound connection to Elanco’s corporate mission and global stakeholder base:

"Elanco’s purpose—food and companionship enriching lives—deeply resonates with me," Preston remarked. "I am excited to partner with our global teams to champion our people, advance workforce innovation and cultivate a culture where our talent thrives as we deliver for veterinarians, pet owners, farmers and the animals in their care."

Reflecting on the legacy of outgoing Chief People Officer Dave Kinard, CEO Jeff Simmons underscored the lasting impact of Kinard’s tenure:

"Today our employee engagement is the highest since our IPO, backed by a culture and brand in a position of strength because of Dave’s dedicated leadership and enduring contributions," Simmons noted. "Dave has been a trusted partner, and we appreciate his commitment to supporting Jamie through the end of the year to ensure continuity for our teams around the world, and we wish him all the best in his well-deserved retirement."

Implications

The appointment of Jamie Preston as Executive Vice President and Chief People Officer carries profound strategic implications for Elanco Animal Health as the company navigates its next phase of market expansion, cultural consolidation, and technological modernization.

1. Acceleration of Workforce Innovation and Digital Transformation

Given Preston’s recent background at Eli Lilly—where she spearheaded enterprise-wide artificial intelligence and workforce modernization initiatives—Elanco is well-positioned to accelerate its own internal digital transformation. In the modern animal health sector, operational efficiency increasingly relies on advanced data analytics, automated human resources platforms, and agile work models. Preston’s expertise in managing global compensation frameworks and large-scale digital workplace strategies will likely inject fresh momentum into Elanco’s efforts to modernize its internal operations and attract tech-savvy talent.

2. Cultural Continuity and Shared Heritage

Because Elanco shares historical roots with Eli Lilly and Company, Preston’s 23-year tenure within the broader Lilly ecosystem provides an immediate cultural alignment. She enters the organization with an innate understanding of science-driven, values-based corporate cultures. This shared heritage is expected to minimize the friction often associated with executive onboarding, allowing Preston to hit the ground running while preserving the high employee engagement levels cultivated by Dave Kinard.

3. Sustaining Post-IPO Cultural Maturation

Since transitioning into an independent, publicly traded company following its separation from Lilly, Elanco has had to consciously construct its own distinct corporate identity, brand ethos, and operational infrastructure. Dave Kinard played a monumental role in this endeavor, overseeing the physical relocation of the headquarters to Indianapolis and establishing the collaborative One Health Innovation District. Preston inherits a stabilized, highly engaged workforce and is now tasked with scaling this culture globally, ensuring that employees across nearly 90 countries remain tethered to Elanco’s core purpose of enriching the lives of animals and people.

4. Strategic Talent Retention in a Competitive Life Sciences Market

The animal health and broader life sciences sectors face intense competition for specialized scientific, commercial, and technical talent. Preston’s extensive international background—highlighted by her multi-market leadership across the Asia-Pacific region and her oversight of total rewards for a 50,000-person workforce—equips her with the sophisticated compensation and talent retention strategies required to navigate a competitive global labor market. Her leadership will be instrumental in ensuring Elanco remains an employer of choice for top-tier veterinarians, researchers, agricultural specialists, and commercial executives worldwide.